Yahoo Finance

Is NeuroVive Pharmaceutical AB’s (STO:NVP) CEO Paid Enough Relative To Peers?

Erik Kinnmann has been the CEO of NeuroVive Pharmaceutical AB (STO:NVP) since 2016. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we’ll consider ...
Yahoo Finance

How Much Did NeuroVive Pharmaceutical AB's (STO:NVP) CEO Pocket Last Year?

Erik Kinnmann became the CEO of NeuroVive Pharmaceutical AB (STO:NVP) in 2016. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, ...
Business Insider

NeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia

LUND, Sweden, Aug. 28, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that scientists at the company's research partner the Children's Hospital ...
Business Wire

NeuroVive Pharmaceutical: Development of NVP014 for the Treatment of Stroke Enters New Phase in Collaboration with Isomerase Therapeutics

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: NeuroVive Pharmaceutical AB (publ)(STO:NVP), the mitochondrial medicine company, has announced that the company’s development project NVP014 for the ...
Pharmabiz

NeuroVive, Isomerase Therapeutics enter collaboration to develop and commercialize cyclophilin-inhibiting molecules

NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, has signed a collaboration agreement with Isomerase Therapeutics to develop the molecules that were recently acquired from ...
Business Wire

NeuroVive Pharmaceutical: NeuroVive’s Chief Operating Officer Jan Nilsson Leaves the Company

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that its Chief Operating Officer, ...
Finanznachrichten

NeuroVive Signs Collaboration Agreement With Karolinska Institutet

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that a collaboration agreement has been signed with Karolinska Institutet, ...
Business Insider

NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study

LUND, Sweden, March 19, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the first healthy volunteer in the company's KL1333 phase Ia/b study ...
Nasdaq

NeuroVive Announces Settlement in Dispute With CicloMulsion AG

LUND, Sweden, Dec. 16, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announced today that it has fully and finally settled the dispute with CicloMulsion AG ...
Nasdaq

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment ...
FierceBiotech

NeuroVive resolves on rights issue totaling approximately SEK 94.4 million for continued development of the project portfolio

On 28 February 2016, The Board of Directors of NeuroVive Pharmaceutical AB (publ) ("NeuroVive" or "the Company") decided to carry out a new issue of shares and warrants (units) with preferential ...